Published

The fibrinolytic system: A new target for treatment of depression with psychedelics.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Medical hypotheses
Date: 2017-03-01
Source: PubMed
DOI: 10.1016/j.mehy.2017.01.013
PubMed: 28236848

Authors

Idell RD Florova G Komissarov AA Shetty S Girard RB Idell S

Watch author

Derived topics and classifications

psilocybin Depression Neuroplasticity Neurogenesis Receptor Pharmacology Inflammation Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01 Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptorsCommunications Biology · 2026-03-26 Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent MannerMolecules · 2024-10-28 Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in ratsFrontiers in Neuroscience · 2023-06-22 Models of psychedelic drug action: modulation of cortical-subcortical circuits.Brain: a journal of neurology · 2022-04-18 Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05 Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.Brain sciences · 2025-02-06